跳到主要內容
big screen image small screen image
Font Size
A
A
A
轉寄 轉寄
(Exclusive License) Technology Transfer Enterprise Selection Announcement - Precision Medicine Platform for Microtracer Development and for Personalized Molecular Imaging Diagnosis
Date of Announcement
2020-10-12
 

Subject

(Exclusive License) Technology Transfer Enterprise Selection Announcement - Precision Medicine Platform for Microtracer Development and for Personalized Molecular Imaging Diagnosis

Content

  • Technology:

Precision Medicine Platform for Microtracer Development and for Personalized Molecular Imaging Diagnosis

  • Provider:

Dr. Ya-Yao Huang

  • Enterprise Eligibility

1. Industry Category: Biotechnology and medicine

2. Required Technical Know-how: Drug development, clinical trial, PET drug manufacturing, and PIC / S GMP

3. Required Machinery and Equipment: Incubator, laminar flow bench, and PET drug manufacturing equipment 4. Radioactive drug manufacturing personnel, animal experimentation personnel, and clinical trial personnel

4. Required Research or Technical Staff: No specific restrictions

5. Other Requirements: No specific restrictions

 

The university's regulations relevant to technology transfer shall be complied with for matters not aforementioned.

 

  • How to apply? Please go to the Center of Industry-Academia Collaboration of the Office of Research and Development to inquire about relevant information.

Contact Person

Alex Kao

TEL: +886-2-33669988

Email: cmkao@ntu.edu.tw

File download:
Technology Transfer Enterprise Selection Announcement - Precision Medicine Platform for Microtracer Development and for Personalized Molecular Imaging Diagnosis
File size: 341kb